Frederique AUBOURG

Dr. Frederique AUBOURG

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Respiratory Research
Verified
Journal Article
Open access
PDF file
ARAnaïs Roeser
Anaïs Roeser
LSLucile Sese
Lucile Sese
CGChassagnon Guillaume
Chassagnon Guillaume
BCBenjamin Chaigne
Benjamin Chaigne
BDBertrand Dunogue
Bertrand Dunogue
YUYurdagül Uzunhan
Yurdagül Uzunhan
Objective: To investigate the association of air pollution exposure with the severity of interstitial lung disease (ILD) at diagnosis and ILD progression among patients with systemic sclerosis (SSc)-associated ILD. Methods: We conducted a retrospective two-center study of patients with SSc-associated ILD diagnosed between 2006 and 2019. Exposure to the air pollutants particulate matter of up to 10 and 2.5 µm in diameter (PM10, PM2.5), nitrogen dioxide (NO2), and ozone (O3) was assessed at the geolocalization coordinates of the patients’ residential address. Logistic regression models were used to evaluate the association between air pollution and severity at diagnosis according to the Goh staging algorithm, and progression at 12 and 24 months. Results: We included 181 patients, 80% of whom were women; 44% had diffuse cutaneous scleroderma, and 56% had anti-topoisomerase I antibodies. ILD was extensive, according to the Goh staging algorithm, in 29% of patients. O3 exposure was associated with the presence of extensive ILD at diagnosis (adjusted OR: 1.12, 95% CI 1.05–1.21; p value = 0.002). At 12 and 24 months, progression was noted in 27/105 (26%) and 48/113 (43%) patients, respectively. O3 exposure was associated with progression at 24 months (adjusted OR: 1.10, 95% CI 1.02–1.19; p value = 0.02). We found no association between exposure to other air pollutants and severity at diagnosis and progression. Conclusion: Our findings suggest that high levels of O3 exposure are associated with more severe SSc-associated ILD at diagnosis, and progression at 24 months.

15 May 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
THThông Hua-Huy
Thông Hua-Huy
CLChristine Lorut
Christine Lorut
FAFrederique AUBOURG
Frederique AUBOURG
CMCaroline Morbieu
Caroline Morbieu
JMJonathan Marey
Jonathan Marey
Anh Tuan Dinh-XuanAnh Tuan Dinh-Xuan
Anh Tuan Dinh-Xuan

Verified
Journal Article
Open access
PDF file
THThông Hua-Huy
Thông Hua-Huy
SGSven Günther
Sven Günther
CLChristine Lorut
Christine Lorut
MSMarielle Subileau
Marielle Subileau
FAFrederique AUBOURG
Frederique AUBOURG
Anh Tuan Dinh-XuanAnh Tuan Dinh-Xuan
Anh Tuan Dinh-Xuan
Pulmonary sequelae as assessed by pulmonary function tests (PFTs) are often reported in patients infected by SARS-CoV-2 during the post-COVID-19 period. Little is known, however, about the status of pulmonary inflammation during clinical recovery after patients’ discharge from the hospitals. We prospectively measured PFTs coupled with the exhaled nitric oxide (NO) stemming from the proximal airways (FeNO) and the distal lung (CaNO) in 169 consecutive patients with varying degrees of the severity of COVID-19 six weeks to one year after acute infection by SARS-CoV-2. The proportions of patients with abnormal PFTs, defined as the presence of either obstructive/restrictive patterns or impaired lung gas transfer, or both, increased with the severity of the initial lung disease (15, 30, and 52% in patients with mild, moderate, and severe COVID-19). FeNO values remained within normal ranges and did not differ between the three groups of patients. CaNO, however, was significantly higher in patients with severe or critical COVID-19, compared with patients with milder forms of the disease. There was also an inverse relationship between CaNO and DLCO. We conclude that the residual inflammation of the distal lung is still present in the post-COVID-19 follow-up period, in particular, in those patients with an initially severe form of COVID-19. This long-lasting alveolar inflammation might contribute to the long-term development of pulmonary fibrosis and warrants the regular monitoring of exhaled NO together with PFTs in patients with COVID-19.

Verified
Journal Article
Open access
PDF file
THThông Hua-Huy
Thông Hua-Huy
HPHa Pham-Ngoc
Ha Pham-Ngoc
FAFrederique AUBOURG
Frederique AUBOURG
CLChristine Lorut
Christine Lorut
NRNicolas Roche
Nicolas Roche
Anh Tuan Dinh-XuanAnh Tuan Dinh-Xuan
Anh Tuan Dinh-Xuan
Impaired lung gas exchange is commonly seen in patients with pulmonary involvement related to SARS-CoV-2 acute infection or post-acute COVID-19 syndrome (PACS). The primary aim of our study was to assess lung gas transfer, measuring the pulmonary diffusion capacity for nitric oxide (DLNO) and carbon monoxide (DLCO) in all COVID-19 patients. Our secondary aim was to decipher the respective roles of perturbed lung membrane conductance (DM) and reduced pulmonary capillary volume (VC) in patients with impaired lung gas exchange. From May to October 2020, we measured DLNO-DLCO in 118 patients during their post-COVID-19 period (4.6 months after infection) to decipher alveolo-capillary gas transfer disturbances. DLNO-DLCO measurement was also performed in 28 healthy non-smokers as controls. Patients were classified into three groups according to the severity (mild, moderate, and severe) of acute COVID-19 infection. Patients with mild COVID-19 had normal lung volumes and airways expiratory flows but impaired pulmonary gas exchange, as shown by the significant decreases in DLNO, DLCO, DM, and VC as compared with controls. VC was significantly impaired and the DLNO/DLCO ratio was increased in patients with moderate (n = 4, 11%) and severe COVID-19 (n = 23, 49%). Abnormal membrane conductance was also seen in all three groups of post-COVID-19 patients. These findings suggest a persistent alveolo-capillary gas transfer defect, implying not only reduced membrane conductance but also abnormal pulmonary vascular capacitance in all PACS patients, even those with a milder form of COVID-19 infection.

5 June 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
HPHa Pham-Ngoc
Ha Pham-Ngoc
THThông Hua-Huy
Thông Hua-Huy
NLNhât-Nam Lê-Dông
Nhât-Nam Lê-Dông
FAFrederique AUBOURG
Frederique AUBOURG
SHStéfanie Habib-Maillard
Stéfanie Habib-Maillard
Anh Tuan Dinh-XuanAnh Tuan Dinh-Xuan
Anh Tuan Dinh-Xuan
Background/Objectives: Airway inflammation and small airway dysfunction (SAD) are key features of asthma. Inflammation can be assessed by blood eosinophil count (Eos) and exhaled nitric oxide (NO) parameters, including fractional exhaled nitric oxide (FeNO), bronchial NO flux (J’awNO), and alveolar NO concentration (CANO), the latter reflecting distal airway inflammation. We aimed to evaluate the association between Eos and the degree of airway inflammation as specified by exhaled NO parameters and to assess the relationships between exhaled NO parameters and small airway dysfunction using spirometric and plethysmographic indices. Methods: We conducted an observational study of asthmatic outpatients who underwent spirometry, plethysmography, and exhaled NO measurements. Multivariable regression models were used to estimate associations between Eos and FeNO, J’awNO, CANO, and spirometric/plethysmographic indices, adjusting for age, sex, body mass index, and relevant covariates. Results: The analytic cohort included 121 patients (49 men; 72 women; median age 54.2 years). Small airway obstruction and a range of airway inflammation severity were observed. Mean (SD) or median [IQR] values, as appropriate, were: FEF75 z-score −0.62 (0.96); FEF25–75 z-score −1.27 (1.29); RV z-score 1.26 (0.94); RV/TLC z-score 1.60 (1.10); J’awNO 60.20 nL/min (102.80); FeNO 23.61 ppb (37.61); CANO 3.80 ppb (4.12); and Eos 260 cells/µL (430). Log-transformed Eos (log[Eos]) was associated with FeNO, J’awNO, and CANO (adjusted marginal slope [95% CI]: 12.11 [9.35–14.69], 33.56 [25.34–41.19], and 1.14 [0.84–1.43], respectively). Log(Eos) was also positively associated with RV and RV/TLC, but negatively associated with FEF25–75, FEF75, and FEV1. Similarly, CANO was positively associated with RV and RV/TLC and inversely associated with FEF25–75 and FEF75. No significant associations were observed for FeNO or J’awNO. Conclusions: Blood eosinophils were independently associated with all exhaled NO parameters. The association between CANO and small airway ventilatory function indices supports a link between distal airway inflammation and SAD in asthma.

21 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
HPHa Pham-Ngoc
Ha Pham-Ngoc
THThông Hua-Huy
Thông Hua-Huy
NLNhât-Nam Lê-Dông
Nhât-Nam Lê-Dông
FAFrederique AUBOURG
Frederique AUBOURG
SHStéfanie Habib-Maillard
Stéfanie Habib-Maillard
Anh Tuan Dinh-XuanAnh Tuan Dinh-Xuan
Anh Tuan Dinh-Xuan
Background/Objectives: Airway inflammation and small airway disease (SAD) are key features of asthma. Inflammation can be assessed by blood eosinophil count (Eos) and exhaled nitric oxide (NO) parameters, including fractional exhaled nitric oxide (FeNO), bronchial NO flux (J’awNO), and alveolar NO concentration (CANO), the latter re-flecting distal airway inflammation. We aimed to evaluate the association between Eos and the degree of airway inflammation as specified by exhaled NO parameters, and their relationships with small airway obstruction assessed by spirometric and ple-thysmographic indices. Methods: We conducted an observational study of asthmatic outpatients who underwent spirometry, plethysmography, and exhaled NO measure-ments. Multivariable linear regression was used to estimate associations between Eos and FeNO, J’awNO, CANO, and small airway ventilatory function indices, adjusting for age, sex, body mass index, and treatments. Results: The analytic cohort included 121 patients (49 men; 72 women; median age 54.2 years). Small-airway obstruction and a range of airway inflammation severity were observed. Median (IQR) values were: FEF75 z-score −0.62 (0.96); FEF25–75 z-score −1.27 (1.29); RV z-score 1.26 (0.94); RV/TLC z-score 1.60 (1.10); J’awNO 60.20 nL/min (102.80); FeNO 23.61 ppb (37.61); CANO 3.80 ppb (4.12); and Eos 260 cells/µL (430). Log-transformed Eos (log[Eos]) was associated with FeNO, J’awNO, and CANO (adjusted β [95% CI]: 12.02 [9.35–14.69], 33.27 [25.34–41.19], and 1.14 [0.84–1.43], respectively). Log(Eos) was also positively associated with RV and RV/TLC, but negatively associated with FEF25–75, FEF75, and FEV1. Similarly, CANO was positively associated with RV and RV/TLC and inversely associated with FEF25–75 and FEF75. No significant associations were observed for FeNO or J’awNO. Conclusions: Blood eo-sinophils were independently associated with all exhaled NO parameters. The associa-tion between CANO and small airway ventilatory function indices supports a link between distal airway inflammation and SAD in asthma.